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Wnt2 secreted by tumour fibroblasts promotes
tumour progression in oesophageal cancer by
activation of the Wnt/b-catenin signalling pathway
Li Fu,1,2 Chunyu Zhang,3 Li-Yi Zhang,2 Sui-Sui Dong,2 Lu-Hui Lu,2 Juan Chen,2
Yongdong Dai,1 Yan Li,1 Kar Lok Kong,2 Dora L Kwong,2 Xin-Yuan Guan1,2
ABSTRACT
Objectives Interaction between neoplastic and stromal
cells plays an important role in tumour progression. It
was recently found that WNT2 was frequently
overexpressed in fibroblasts isolated from tumour tissue
tumour fibroblasts (TF) compared with fibroblasts from
non-tumour tissue normal fibroblasts in oesophageal
squamous cell carcinoma (OSCC). This study aimed to
investigate the effect of TF-secreted Wnt2 in OSCC
development via the tumourestroma interaction.
Methods Quantitative PCR, western blotting,
immunohistochemistry and immunofluorescence were
used to study the expression pattern of Wnt2 and its
effect on the Wnt/b-catenin pathway. A Wnt2-secreting
system was established in Chinese hamster ovary cells
and its conditioned medium was used to study the role
of Wnt2 in cell proliferation and invasion.
Results Expression of Wnt2 could only be detected in TF
but not in OSCC cancer cell lines. In OSCC tissues, Wnt2
(+) cells were mainly detected in the boundary between
stroma and tumour tissue or scattered within tumour
tissue. In this study, Wnt2-positive OSCC was defined
when five or more Wnt2(+) cells were observed in
2003 microscopy field. Interestingly, Wnt2-positive
OSCC (22/51 cases) was significantly associated with
lymph node metastases (p¼0.001), advanced TNM
stage (p¼0.001) and disease-specific survival
(p<0.0001). Functional study demonstrated that
secreted Wnt2 could promote oesophageal cancer cell
growth by activating the Wnt/b-catenin signalling
pathway and subsequently upregulated cyclin D1 and
c-myc expression. Further study found that Wnt2 could
enhance cell motility and invasiveness by inducing
epithelialemesenchymal transition.
Conclusions TF-secreted Wnt2 acts as a growth and
invasion-promoting factor through activating the
canonical Wnt/b-catenin signalling pathway in
oesophageal cancer cells.
Mounting evidence suggests that the tumour
microenvironment, composed of non-cancer cells
and their stroma, plays an important role in cancer
development and progression.1 2 Our previous study
has described a broad range of deregulated genes
between fibroblasts isolated from oesophageal
squamous cell carcinoma (OSCC) and their adjacent
non-tumorous oesophageal tissues. Approximately
43% (126/292) of known deregulated genes in
tumour fibroblasts (TF) were associated with cell
proliferation, extracellular matrix remodelling and
immune response.3 Notably, several members of the
Wnt pathway, including WNT2, WNT5A, LEF1 and
WISP1, were upregulated in TF, suggesting that Wnt
signalling might be involved in the tumourestromal
interactions in oesophageal cancer.3
The Wnt proteins are secreted ligand proteins
(approximately 40 kDa in size) that act in a para-
crine fashion by activating diverse signalling
cascades inside their target cells. The Wnt signalling
pathway diversifies into three main branches.4 The
best understood is the so-called canonical pathway,
which activates target genes through stabilisation of
b-catenin in the nucleus. Wnt proteins can also
signal by activating calmodulin kinase II and protein
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Significance of this study
What is already known about this subject?
< Tumour fibroblasts (TF) play an essential role in
the complex process of tumourestroma
interactions and tumourigenesis.
< The WNT2 gene is frequently overexpressed in
fibroblasts isolated from tumour tissue (TF)
compared with fibroblasts from non-tumour
tissue normal fibroblast in oesophageal
squamous cell carcinoma (OSCC).
< The specific roles of TF-secreted Wnt2 in the
oesophageal cancer microenvironment are still
unknown.
What are the new findings?
< Wnt2 displays unique expression patterns in
OSCC and correlates with the unfavourable clinical
features and survival of patients with OSCC.
< TF-secreted Wnt2 can promote oesophageal
cancer cell growth by activating Wnt/b-catenin
signalling and its downstream targets cyclin D1
and c-myc.
< TF-secreted Wnt2 can enhance oesophageal
cancer cell motility and invasiveness by
inducing epithelialemesenchymal transition.
How might it impact on clinical practice in the
foreseeable future?
< Based on our findings, future therapeutic targets
for interfering with Wnt signalling include cell
surface receptors and secreted signalling mole-
cules, which mediate signalling between cancer
cells and the stromal environment, and may
serve as effective treatment approaches to
patients with OSCC.
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kinase C (known as the Wnt/Ca2+ pathway), which involves an
increase in intracellular calcium (Ca2+), or Jun N-terminal kinase
(known as the planar cell polarity pathway), which controls
cytoskeletal rearrangements and cell polarity. The canonical Wnt
pathway is the most prevalent Wnt signalling pathway in the
development of cancer. The Wnt2 gene, located on chromosome
7q31.3, is highly expressed in fetal lungs and weakly expressed in
the placenta.5 Blasband et al6 has reported that overexpression of
Wnt2, with signalling through b-catenin, promotes trans-
formation of mammary epithelial cells in the mouse cell line
C57MG, demonstrating the oncogenic activity of Wnt2.
As some Wnt ligands are stromally secreted with cognate
receptors expressed by the epithelia, Wnt proteins are good
candidates for mediating tumourestromal interactions.7 8 Our
previous study has identified WNT2 as one of the upregulated
WNT genes in TF isolated from primary OSCC. In the present
study, we further investigated the role of Wnt2 secreted by TF in
OSCC tumourigenesis. Our results showed that Wnt2-positive
expression was significantly correlated with poor clinical
outcomes of OSCC patients. We also demonstrated that secreted
Wnt2 acts as a growth and invasion-promoting factor through
activating the canonical Wnt/b-catenin signalling pathway in
oesophageal cancer cells.
MATERIALS AND METHODS
Cell lines and primary tumour specimens
Two Chinese OSCC cell lines (EC18 and EC109) were kindly
provided by Professor Tsao GS (Department of Anatomy, The
University of Hong Kong). Five Japanese OSCC cell lines
(KYSE30, KYSE140, KYSE180, KYSE410 and KYSE510) were
obtained from DSMZ (Braunschweig, Germany), the German
Resource Centre for Biological Material.9 The Chinese hamster
ovary cell line (CHO-K1) was purchased from the American
Type Culture Collection (Manassas, Virginia, USA). Primary
OSCC tissues and their adjacent normal oesophageal tissues
were collected immediately after surgical resection in the Cancer
Center of Sun Yat-sen University (Guangzhou, China). A total of
51 formalin-fixed and paraffin-embedded OSCC were also kindly
provided by the Cancer Center of Sun Yat-sen University. The
clinical data of patients included in this study are detailed in
supplementary table S1 (available online only). All patients did
not receive preoperative treatment. Clinical samples used in this
study were approved by the Committee for Ethical Review of
Research at Sun Yat-sen University.
Isolation of fibroblasts
TF and their matched normal fibroblasts were isolated from
primary OSCC as described previously.3 Briefly, freshly collected
OSCC tumour tissue and its paired non-tumorous oesophageal
tissue were cut into as small pieces as possible in sterile phos-
phate-buffered saline (PBS) solution, followed by collagenase
digestion. The suspension was filtered through 20 mm stainless
steel wire mesh to collect a single cell suspension. The filtrate
was centrifuged and washed before being finally plated on 6 cm
tissue culture dishes in 5 ml DMEM medium supplemented
with 20% fetal bovine serum (FBS). After culturing for 30 min at
378C, unadherent cells (mainly tumour cells) were removed
to obtain pure fibroblasts. The adherent fibroblasts were
subcultured for further study.
Plasmid construction and transfection
The WNT2 gene was PCR amplified, cloned into pcDNA3.1/V5-
His TOPO TA vector (Invitrogen, Carlsbad, California, USA),
and transfected into CHO cells using Lipofectamine 2000
(Invitrogen), following the manufacturer ’s instructions. Stably
Wnt2-expressing clones (CHO-Wnt2) were screened. CHO cells
transfected with the empty pcDNA3.1 vector (CHO-Vec) were
used as control.
Conditioned medium
Stably Wnt2-expressing cells (CHO-Wnt2) and empty vector
transfected cells (CHO-Vec) were cultured in DMEM medium
with 10% FBS until 70% confluence. After complete removal of
the normal culture medium, CHO-Wnt2 and CHO-Vec cells
were continually cultured in DMEM medium with 3% FBS for
24 h before medium collection. Culture medium was then
centrifuged at 1000 g for 30 min and the supernatant was
collected as conditioned medium for further study.
Quantitative and semiquantitative RTePCR
Total RNA was extracted by Trizol (Invitrogen). Two micro-
grams of total RNAwas used to synthesise complimentary DNA
with the Advantage RT-for-PCR Kit (Clontech Laboratories, Inc,
Mountain View, California, USA), following the standard
protocols provided by the manufacturer. Semiquantitative
reverse transcriptase (RT)ePCR was performed by using
AmpliTaq (Applied Biosystems, Foster City, California, USA).
GAPDH was used as a control. For quantitative real-time PCR
(qPCR), cDNA products were amplified using a SYBR Green
PCR Kit (Applied Biosystems). The amplification protocol
consisted of incubations at 958C for 15 s, 608C for 1 min and
728C for 1 min for 40 cycles. Quantification was done using the
ABI PRISM 7900HT sequence detection system (Applied
Biosystems). All gene expression values were normalised using
the housekeeping genes GAPDH and calculated using the
comparative CT method (DD CT method).3
Immunohistochemical staining
Immunohistochemical staininh was performed using a standard
streptavidinebiotineperoxidase complex method. In brief,
paraffin block sections of oesophageal cancers were deparaffi-
nised, blocked with 10% normal rabbit serum for 10 min, and
incubated with rabbit anti-human Wnt2 polyclonal antibody
(MBL, 1:150 dilution) overnight at 48C. The slides were then
incubated with biotinylated goat anti-rabbit immunoglobulin at
a concentration of 1:100 at 378C for 30 min. The status of the
cytoplasmic expression of Wnt2 was assessed by three inde-
pendent investigators without previous knowledge of clinico-
pathological data. Positive expression of Wnt2, primarily
a cytoplasmic pattern, was mostly detected in the stromal
compartment within tumour tissue. In the present study,
a positive result was defined when five or more Wnt2-positive
cells were detected per microscopy field (203 in magnification).
Immunofluorescence
Cells cultured with conditioned medium from Wnt2-expressing
CHO cells and control cells were grown on gelatin-coated
coverslips for the indicated time points and then fixed in 4%
p-formaldehyde at room temperature for 20 min. Cells were
incubated with PBS-B solution at 378C for 30 min to block non-
specific interactions and stained with anti-b-catenin mouse
monoclonal antibody (Immunofluorescence (IF) Preferred; Cell
Signalling Technology, Danvers, Massachusetts, USA) at 48C
overnight. After several washes in PBS, cells were incubated
with optimal concentrations of FITC-labelled goat anti-mouse
secondary antibody (eBioscience, San Diego, California, USA)
at room temperature for 1 h. Anti-fade DAPI solution was
added and images were obtained. For immunofluorescence
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double-labelling, paraffin block sections of oesophageal cancers
were incubated with a mouse antibody against vimentin and
a rabbit antibody against Wnt2 simultaneously at 378C over-
night. After brief washing, slides were incubated with FITC goat
anti-mouse (eBioscience) and Texas-red goat anti-rabbit (eBio-
science) secondary antibodies at room temperature for 1 h. After
brief washing, slides were counterstained with DAPI in anti-fade
solution.
Cell proliferation assay
To test the effect of Wnt2 secretion on cell growth rate, KYSE30
and EC109 cells were seeded onto 96-well plates at a density of
23103 per well. After 24-h incubation, normal growth media
was replaced by conditioned medium from Wnt2-expressing
clones and control cells. The cell growth rate was detected using
the cell proliferation XTT kit (Sigma, St Louis, Missouri, USA)
according to the manufacturer ’s instruction.
Migration and invasion assays
For cell migration assay, KYSE30 and EC109 cells were grown to
confluence and then mechanically scratched with a sterile pipette
tip. Cells were rinsed with PBS and grown in CHO-Wnt2
conditioned medium and CHO-Vec conditioned medium for an
additional 72 h. The cell motility in terms of wound closure was
measured by photographing at three random fields at time points
0 and 72 h. For invasion assay, KYSE30 and EC109 cells were
starved with serum-free medium for 24 h before the assay. Cells
(53104) were suspended in 0.5 ml serum-free medium and loaded
on the upper compartment of the invasion chamber coated with
Matrigel (BD Biosciences, Franklin Lakes, NJ, USA). The lower
compartment was filled with CHO-Wnt2 conditioned medium
and CHO-Vec conditioned medium as chemoattractant. After
48 h, invasive cells were fixed, stained and counted under
a microscope. Three independent experiments were done with
triplicates each time for both migration and invasion assays.
Western blotting analysis
Western blotting was done according to the standard protocol
with antibodies for rabbit anti-Wnt2 (R&D Systems, Minne-
apolis, Minnesota, USA; 1:400), rabbit anti-cyclin D1, -c-myc,
a-catenin, and b-catenin (Cell Signalling Technology; 1:1000),
and mouse anti-E-cadherin, a-SMA, -Vimentin and b-actin
(Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:2000).
Statistical analysis
Statistical analysis was performed using SPSS standard V.13.0
software. Data are expressed as mean6SD from at least three
independent determinations. Significance of difference was
analysed using Student’s t tests. The correlation between Wnt2
expression and clinicopathological characteristics was analysed
using Fisher ’s exact test. Disease-specific survival was calculated
from the date of diagnosis to the date of cancer-related death or
last follow-up. Survival curves was assessed by the
KaplaneMeier method and compared by the log-rank test.
Differences were considered significant for p<0.05.
RESULTS
Wnt2 is overexpressed mainly in OSCC TF
qPCR was used to compareWNT2 expression status between TF
and normal fibroblasts isolated from 10 primary OSCC.
Consistent with our previous finding,3 WNT2 expression was
approximately fourfold higher in the TF than the normal
fibroblasts (figure 1A). Statistical analysis showed that the
difference in WNT2 expression was significant (p<0.05,
independent Student’s t test) between normal fibroblasts
and TF. Western blot analysis confirmed that the expression of
Wnt2 protein was also higher in TF than that in normal fibro-
blasts (figure 1B). Interestingly, no visible protein expression
of Wnt2 was detected in all tested OSCC cancer cell lines
(figure 1C).
Distribution of Wnt2-positive cells in primary OSCC
To study further the distribution of Wnt2(+) cells in OSCC,
immunohistochemical staining was used to detect Wnt2
expression cells in 51 primary OSCC cases. Wnt2(+) cells were
almost undetectable in adjacent non-tumorous oesophageal
tissue (figure 2A). In OSCC tissues, Wnt2(+) cells could be
detected in 42/51 (82.4%) cases. Wnt2(+) cells were mainly
detected in the boundary between stroma and tumour tissue,
stroma between tumour nests and scattered within tumour
tissue (figure 2A). Two-colour (green vimentin; red Wnt2)
staining immunofluorescence confirmed that Wnt2 and
vimentin were co-expressed in the same cells, suggesting that
Wnt2(+) cells were fibroblasts (figure 2B,C). Wnt2-positive
OSCC, which was defined when five or more Wnt2(+) cells
were observed in 2003 microscopy field, was detected in 22/51
(43.1%) of OSCC in the present study.
The correlation of Wnt2-positive expression with OSCC
prognosis
Correlation of the Wnt2-positive expression with clinicopatho-
logical features was studied in 51 OSCC. The results found that
Wnt2(+) OSCC was significantly associated with TNM stage
(p¼0.001, Fisher ’s exact test) and lymph node metastasis
(p¼0.001, Fisher ’s exact test; table 1). Furthermore, the log rank
test showed that the disease-specific survival of OSCC with
Wnt2(+) OSCC (median survival time, 16 months) was signif-
icantly shorter than patients with Wnt2() OSCC (median
survival time, 51 months; p<0.0001; figure 3).
Establishment of secreted Wnt2 conditioned medium
To investigate further the effect of secreted Wnt2 on OSCC cells,
an in-vitro Wnt2 secreting system was established using CHO
cells. Briefly, Wnt2 expression plasmid was stably transfected
into CHO cells (CHO-Wnt2), and empty vector-transfected
CHO cells (CHO-Vec) were used as controls. After a short
Figure 1 Detection of Wnt2 expression in oesophageal squamous cell
carcinoma (OSCC). (A) Relative expression level of WNT2 was analysed
by quantitative real-time PCR in tumour fibroblasts (TF) and their paired
normal fibroblasts (NF) in 10 OSCC cases. GAPDH was used as
endogenous control. Data represent the mean6SD derived from three
independent experiments (**p<0.01, independent Student’s t test). (B)
Representative of Wnt2 expression in protein level detected by western
blot analysis. b-actin was used as loading control. (C) No expression of
Wnt2 was detected in OSCC cancer cell lines by western blot analysis.
b-Actin was used as an internal control.
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culture (24 h) in 3% FBS, culture medium was collected as
conditioned medium for further study (figure 4A). The ecpotic
expression of Wnt2 in CHO cells was confirmed at both
messenger RNA and protein (figure 4B) levels. Secreted Wnt2
was also detected in the conditioned medium collected from
CHO-Wnt2 cells (figure 4B).
Secreted Wnt2 promotes cell proliferation in OSCC cells
To analyse the effect of Wnt2 on cell proliferation, OSCC cell
lines (KYSE30 or EC109) were incubated in DMEM medium
with 10% FBS, conditioned medium from CHO-Wnt2 or CHO-
Vec cells, respectively, for 4 days. Cell proliferation (XTT) assay
showed that the cell growth rate was significantly higher
(p<0.001) in cells cultured with conditioned medium from
CHO-Wnt2 than that of cells cultured with conditioned
medium from CHO-Vec (figure 4C,D).
Wnt2 promotes cell proliferation via nuclear translocation of
b-catenin
In an attempt to explore the potential molecular mechanism of
the proliferating promotion effect of secreted Wnt2 on OSCC,
the Wnt/b-catenin signalling pathway in KYSE30 and EC109
cells was characterised. Immunofluorescence was used to visu-
alise the localisation of b-catenin at different time points (0, 1, 2
and 6 h) after Wnt2-conditioned medium incubation. As shown
in figure 5A, b-catenin was mainly localised on the membrane
of KYSE30 cells before incubation with the CHO-Wnt2
conditioned medium (CHO-Wnt2 conditioned medium). After
incubation with CHO-Wnt2 conditioned medium for 1 h,
Figure 2 Distribution of Wnt2(+)
cells in oesophageal squamous cell
carcinoma (OSCC). (A) Immunostaining
with anti-Wnt2 antibody showed that
Wnt2(+) cell was seldom observed in
normal esophageal tissue. In OSCC,
Wnt2(+) cell (indicated by arrows)
was frequently observed in tumour/
stroma boundary, stroma between
tumour nests and scattered within
tumour tissue. 3200 in magnification.
Scale bars 20 mm. (B) Representative of
Wnt2(+) cells (indicated by arrows)
detected in tumour/stroma boundary by
two-colour immunofluorescent staining
with antibodies against vimentin (green
colour) and Wnt2 (red colour). Nuclei
were counterstained with DAPI (blue
colour). Scale bar 20 mm. (C)
Representative images of tumour
fibroblasts (TF) and normal fibroblasts
(NF) labelled by antibodies against
vimentin (green colour) and Wnt2 (red
colour). Nuclei were counterstained
with DAPI (blue colour). Scale bar
10 mm.
Table 1 Association of positive Wnt2 expression with
clinicopathological features in 51 OSCC
Clinicopathological
characteristics N
Wnt2 expression no (%)
Wnt2(+) Wnt2(L) p Value
Age (years)
#57 25 11 (44.0) 14 (56.0) 0.903
>57 26 11 (42.3) 15 (57.7)
Sex
Male 39 19 (48.7) 20 (51.3) 0.192
Female 12 3 (25.0) 9 (75.0)
TNM stage
I 2 0 (0) 2 (100) 0.001*
II 31 8 (25.8) 23 (74.2)
III 18 14 (77.8) 4 (22.2)
Lymph node metastasis
N0 23 4 (17.4) 19 (82.6) 0.001*
N1 28 18 (64.3) 10 (35.7)
*p<0.05 (Fisher’s exact test).
OSCC, oesophageal squamous cell carcinoma.
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membranous b-catenin started to enter the cytoplasm of
KYSE30 cells. At 2 h, b-catenin was translocated into the
nucleus. Interestingly, b-catenin appeared in the membrane of
KYSE30 cells again after 6 h incubation with CHO-Wnt2
conditioned medium (figure 5A). As expected, nuclear trans-
location of b-catenin could not be observed when KYSE30 cells
were incubated with CHO-Vec conditioned medium (figure 5A).
To investigate whether the nuclear translocation of b-catenin
could upregulate the expression of its downstream targets,
expressions of cyclin D1 and c-myc at both mRNA and protein
levels were compared between KYSE30 cells cultured with
CHO-Wnt2 conditioned medium and CHO-Vec conditioned
medium by qPCR and western blot analysis. qPCR results
showed that expressions of CCND1 and MYC in KYSE30 cells
were increased 1 h after culture with CHO-Wnt2 conditioned
medium compared with cells cultured with CHO-Vec condi-
tioned medium (figure 5B). At 2 h, expressions of CCND1 and
MYC were significantly increased in KYSE30 cells incubated
with CHO-Wnt2 conditioned medium compared with cells
incubated with CHO-Vec conditioned medium. At 4 h, expres-
sions of CCND1 and MYC were decreased to the levels before
CHO-Wnt2 conditioned medium treatment (figure 5B). No
increased CCND1 andMYC expression was observed in KYSE30
cells treated with CHO-Vec conditioned medium.
Similarly, elevated protein levels of cyclin D1 and c-myc in
response to the nuclear translocation of b-catenin were also
detected by western blot analysis (figure 5C). Increased cyclin
D1 and c-myc expression was detected at 2 h and 4 h after
CHO-Wnt2 conditioned medium treatment (figure 5C). No
increased cyclin D1 and c-myc expression was observed in
KYSE30 cells treated with CHO-Vec conditioned medium. To
confirm further the effect of Wnt2 on b-catenin translocation
and the subsequent cyclin D1 and c-myc upregulation, OSCC
cell line EC109 cells were also treated with CHO-Wnt2 condi-
tioned medium and CHO-Vec conditioned medium. Similar
effects of Wnt2 on the nuclear translocation of b-catenin, as well
as the upregulation of cyclin D1 and c-myc, were observed when
cells were incubated with CHO-Wnt2 conditioned medium
(figure 6).
Wnt2 enhances cell motility and invasiveness via
epithelialemesenchymal transition
As our correlation study showed that the positive expression of
Wnt2 was closely associated with OSCC metastasis, the meta-
static role of Wnt2 was studied by wound-healing and invasion
assays. In the wound-healing assay, no significant difference was
observed between CHO-Vec and CHO-Wnt2 conditioned
medium cultured KYSE30 or EC109 cells over a 24-h incubation.
As shown in figure 7A, CHO-Wnt2 conditioned medium could
dramatically enhance cell migration ability in OSCC cells at 72 h
after incubation, compared with control conditioned medium
(p<0.05). Subsequently, we measured the capacity of OSCC
cells to invade through matrigel, an artificial extracellular matrix,
after incubation with CHO-Wnt2 conditioned medium or
control conditioned medium. KYSE30 and EC109 cells cultured
with CHO-Wnt2 conditioned medium showed an increased
invasion by 53% and 75%, respectively (p<0.01; figure 7B).
Figure 3 Overexpression of Wnt2 was associated with poor prognosis
of oesophageal squamous cell carcinoma determined by KaplaneMeier
analysis. Black, patients with negative Wnt2 expression (n¼29, median
survival 51 months); grey, patients with positive expression of Wnt2
(n¼22, median survival 16 months; **p<0.0001, log-rank test). Figure 4 Secreted Wnt2 promotes cell proliferation in oesophagealsquamous cell carcinoma (OSCC) cells. (A) Schematic diagram of the
Wnt2-secretion system established in Chinese hamster ovary (CHO)
cells. Plasmid containing WNT2 was stably transfected into CHO cells
and conditioned medium (CM) containing secreted Wnt2 was collected
for further study. (B) Expression ofWNT2 in Wnt2-transfected CHO cells
(CHO-W) was confirmed by reverse transcriptase (RT)ePCR (left).
Western blot analysis showed that Wnt2 protein could be detected in
both CHO-W cells and conditioned medium of CHO-W (right). CHO-V,
empty vector-transfected CHO cells. (C and D) The effect of normal
growth media (DMEM + 10% fetal bovine serum), control-conditioned
media (CHO-Vec conditioned medium), or Wnt2-conditioned media
(CHO-Wnt2 conditioned medium) on the growth of OSCC tumour cells
(KYSE30 and EC109) was compared by XTT assay. The results are
expressed as mean6SD of three independent experiments. *p<0.05,
independent Student’s t test.
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To determine whether the effect of Wnt2 on cell migration
and invasion was associated with epithelialemesenchymal
transition, expressions of several epithelial markers (a-catenin,
b-catenin and E-cadherin) and mesenchymal markers (a-SMA
and vimentin) were compared between CHO-Wnt2 condi-
tioned medium and control conditioned medium cultured
OSCC cells at the 6-h time point by western blot analysis.
Except for the absent expression of E-cadherin in EC109 cells,
the results showed that the expression of all the tested
epithelial markers was significantly downregulated, whereas
the mesenchymal markers were upregulated in CHO-Wnt2
conditioned medium cultured KYSE30 and EC109 cells
(figure 7C). These findings indicated that Wnt2 increased cell
migration and invasion was through epithelialemesenchymal
transition.
DISCUSSION
The role of the Wnt signalling pathway in normal development
and organogenesis has been widely investigated in recent
years.10e13 An aberrantly activated Wnt signalling pathway may
lead to the development of cancer.14 15 Among members of the
human WNT gene family, WNT2 has been reported as a proto-
oncogene with the potential to activate the WNT/b-catenin
signalling pathway. Upregulation of Wnt2 has been detected in
colorectal cancer,16 gastric cancer17 and oesophageal adenocar-
cinoma.18 In the present study, we found that Wnt2 was seldom
expressed in OSCC tumour cells. However, Wnt2(+) cells could
be detected in 82.4% of primary OSCC cases, mainly distributed
in the boundary between tumour and its surrounding stroma
tissues, or in the stroma tissue between tumour nests, or
scattered within tumour tissue. This distribution pattern is
Figure 5 Secreted Wnt2 induces
nuclear translocation of b-catenin and
activates Wnt/b-catenin signalling
pathway in KYSE30 cells. (A)
Representative immunofluorescence
images showing that the translocation
of b-catenin from the membrane to
nucleus was only detected in KYSE30
cells treated with CHO-Wnt2
conditioned medium (CM) but not with
CHO-Vec conditioned medium at the
indicated time points. Antibody against
b-catenin was labelled with green
colour and nuclei were counterstained
with DAPI (blue colour). 3400 in
magnification. Scale bars 20 mm. (B)
Expression of b-catenin regulated
targets CCND1 andMYC was compared
by quantitative real-time PCR between
KYSE30 cells treated with CHO-Wnt2
conditioned medium and CHO-Vec
conditioned medium at the indicated
time points. GAPDH was used as
endogenous control. Data represent the
mean6SD derived from three
independent experiments (*p<0.05;
**p<0.01, independent Student’s
t test). (C) Expression of cyclin D1 and
c-myc was also compared by western
blot analysis between KYSE30 cells
treated with CHO-Vec conditioned
medium (V) and CHO-Wnt2 conditioned
medium (W) at the indicated time
points. b-Actin was used as a loading
control. The relative expression ratio to
b-actin was summarised in the right
panel.
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similar to that of FGFR2(+) cells, which have been shown to be
TF in our previous study.3 An immunofluorescence study with
antibodies to Wnt2 and the fibroblast marker vimentin showed
that Wnt2 and vimentin were co-expressed in the same cells,
suggesting that Wnt2(+) cells were TF. In addition, OSCC
patients with more Wnt2(+) cells in OSCC tissue had shorter
survival times, and the association was significant (p<0.0001).
These data suggest that Wnt2 might play an important role in
the development and progression of OSCC.
To investigate the effect of TF-secreted Wnt2 on oesophageal
cancer cell growth, we established an in-vitro Wnt2 secretion
system. The conditional medium collected from cultured CHO-
Wnt2 cells, which contains secreted humanWnt2, could promote
cell growth. This finding suggests that Wnt2 secreted by TF can
modulate the growth of cancer cells during tumour development.
Secreted WNT proteins act on target cells by binding to two
distinct families of cell surface receptors: the Frizzled receptors
and the single-pass transmembrane low-density lipoprotein
receptor-related proteins 5 and 6.19 These receptor complexes
transduce a signal to b-catenin via dishevelled proteins. In normal
cells, most of the b-catenin molecules are localised at the plasma
membrane where they link E-cadherin to the actin cytoskeleton
via a-catenin. In addition, b-catenin is inactivated by a multi-
molecular complex containing the adenomatous polyposis coli
protein, axin, and glycogen synthase kinase-3b (GSK-3b). Phos-
phorylation of b-catenin by GSK-3b results in its ubiquitination
and proteolysis. Canonical Wnt signalling inhibits b-catenin
degradation by inactivation of GSK-3b. Hypophosphorylated
b-catenin then translocates to the nucleus, where it binds to
transcription factors of the T-cell factor/lymphocyte enhancer
factor (TCF/LEF) family and initiates transcription of target
genes, such as MYC, CCND1 and MMP7.20 Noteworthily, the
Figure 6 Secreted Wnt2 activates
Wnt/b-catenin signaling pathway in
EC109 cells. (A) Representative
immunofluorescence images of
b-catenin (green) subcellular location in
EC109 cells treated with CHO-Wnt2
conditioned medium (CM) at the
indicated time points. Nuclei were
counterstained with DAPI (blue). 3400
in magnification. Scale bars 20 mm. (B).
Expression of b-catenin regulated
targets CCND1 andMYC was compared
by quantitative real-time PCR between
EC109 cells treated with CHO-Wnt2
conditioned medium and CHO-Vec
conditioned medium at the indicated
time points. GAPDH was used as
endogenous control. Data represent the
mean6SD derived from three
independent experiments (**p<0.01,
independent Student’s t test). (C)
Expression of cyclin D1 and c-myc was
detected by western blot analysis in
EC109 cells treated with CHO-Vec
conditioned medium (V) and CHO-Wnt2
conditioned medium (W) at the
indicated time points. b-Actin was used
as a loading control. The relative
expression ratio to b-actin was
summarised in the right panel.
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downstream effect of b-catenin on promoting cell proliferation
might be a feedback response of Wnt2 on oesophageal cancer
cells. Therefore, it would be interesting to study further the
influence of b-catenin knockdown on cell proliferation, migration
and invasion, which could exclude the effects that are not caused
by b-catenin signalling.
In the present study, we found that secreted Wnt2 could
activate the canonical Wnt signalling pathway, which was
characterised by b-catenin accumulation in the cytoplasm,
translocation into the nucleus and activation of transcription of
Wnt target genes including MYC and CCND1. Our results
clearly showed that b-catenin was accumulated in the cyto-
plasm at 1 h and entered into the nucleus at 2 h after oesopha-
geal cancer cells treated with CHO-Wnt2 conditioned media,
suggesting that the presence of Wnt2 in the conditioned media
successfully activated the canonical Wnt signalling pathway.
Interestingly, nuclear b-catenin was declined while membra-
nous b-catenin was increased after 6 h of incubation with CHO-
Wnt2 conditioned medium, resulting in a decrease of c-myc and
cyclin D1 compared with those seen at 2 h and 4 h. It has also
been reported that Wnt-1 conditioned media led to an accu-
mulation of cytoplasmic b-catenin in OSCC cells at 1.5 h and
sustained until 4 h after incubation.21 Taken together, these
findings suggest that secreted Wnt2 may act as an initiating
factor during the stromaleepithelial interaction. However, the
subsequent crosstalk between the Wnt2-mediated signalling
pathway and other signalling networks, which contribute to
cancer cell proliferation, need to be investigated further.
As a key component of the Wnt signalling pathway, b-catenin
has been implicated in many human cancers,22 and its oncogenic
potential has been extensively studied in in-vitro tissue culture
models23 24 and in-vivo animal models.25e28 The stabilisation of
b-catenin, lack of degradation and ultimately nuclear accumu-
lation is used as evidence of an activated Wnt/b-catenin
pathway. Mutations, including large interstitial deletions
involving exon 3 of the b-catenin gene, have been found to lead
to the accumulation of b-catenin in the cytoplasm and nucleus
of cancer cells in several types of cancers.29e31 However, muta-
tions in b-catenin are not responsible for the abnormal local-
isation of b-catenin in OSCC.32 33 Nuclear accumulation of
b-catenin has also been observed in Barrett’s oesophagus,
a precursor of adenocarcinoma of the distal oesophagus,34e36
suggesting an involvement of Wnt signalling in the pathogenesis
of both adenocarcinomas and squamous cell carcinomas of the
Figure 7 Secreted Wnt2 promotes
cell mobility and invasion by inducing
epithelialemesenchymal transition.
(A) The effect of Wnt2 on cell migration
was determined by wound-healing
assay. During a period of 72 h, the
spreading speed of CHO-Wnt2
conditioned medium (CM)-treated cells
along the wound edge was faster than
that in CHO-Vec conditioned medium-
treated cells. (B) Representative images
showed the CHO-Wnt2 and CHO-Vec
conditioned medium-treated cells that
invaded through the matrigel. The
number of invaded tumour cells was
quantified in the right panel. Columns,
mean of triplicate experiments;
**p<0.01. (C) Expressions of epithelial
markers a-catenin, b-catenin and
E-cadherin and mesenchymal markers
a-SMA and vimentin were compared by
western blotting analysis between CHO-
Wnt2 and CHO-Vec-treated KYSE30 and
EC109 cells. b-actin was used as
a loading control.
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oesophagus. Further analysis showing a fraction of OSCC
tumour cells have abnormal nuclear accumulation of b-catenin
accompanied by increased stromal Wnt2 expression would
improve our understanding of the growth-promoting effect of
secreted Wnt2 in vivo.
Another interesting finding of this study is the promoting
effect of Wnt2 on tumour metastasis in OSCC. Our data
showed that exogenous Wnt2 could promote cell motility and
invasiveness of OSCC cells in vitro. This mirrored the findings of
Wnt2(+) OSCC was significantly associated with advanced
clinical stage and lymph node metastasis. Increasing attention
towards the role of epithelialemesenchymal transition as
a critical component of metastasis37 has been thought to
underlie the spread of malignant cells from a primary carcinoma
to distant sites.38 Several studies suggest that the Wnt/b-catenin
signal pathway may play an important role in epitheliale
mesenchymal transition. Indeed, our results showed that
b-catenin entered into the nucleus at 2 h and removed from the
nucleus to membrane at 6 h with the presence of Wnt2.
Furthermore, we detected the decreased total protein level of
b-catenin at 6 h after incubation with Wnt2, accompanied
by the decreased expression of a-catenin and E-cadherin
and increased expression of a-SMA and vimentin. These
results strongly suggested that the Wnt2eb-catenine
epithelialemesenchymal transition pathway may play a critical
role in OSCC progression.
In summary, we report that TF-secreted Wnt2 acts in a para-
crine manner in oesophageal cancer initiation and progression by
activating the canonical Wnt/b-catenin signalling pathway.
Despite the importance of tumourestromal interactions, our
knowledge of the genes that mediate changes in the tumour
microenvironment and tumourestromal interactions in oeso-
phageal cancer is still limited. Based on our findings, future
therapeutic targets for interfering with Wnt signalling include
cell surface receptors and secreted signalling molecules, which
mediate signalling between cancer cells and the stromal envi-
ronment, and may serve as effective treatment approaches to
OSCC patients.
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